Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2013-08-29

Clinical Trial Update: A Safety and Efficacy Study of Abiraterone Acetate in Participants With Prostate Cancer Who Have Failed Hormone Therapy [Phase 1, Phase 2]

View source ↗

Summary

Phase 1/2 trial evaluating safety and preliminary efficacy of abiraterone acetate in men with prostate cancer who progressed after hormone therapy; results were…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Abiraterone acetate (Abiraterone acetate)

Snippet

Sponsor: Cougar Biotechnology, Inc. | Conditions: Prostatic Neoplasms | Phase 1, Phase 2 | Status: COMPLETED | Results posted: 2013-08-29